Background Hypertrophic cardiomyopathy (HCM) is one of the commonest inheritable
cardiac disorders. Being a global disease with diffuse myocardial fibrosis, it has a wide …

Background Myocardial fibrosis was shown to influence prognosis in hypertrophic
cardiomyopathy (HCM). It is typically assessed by late gadolinium enhancement (LGE) on …

Objective. In hypertrophic cardiomyopathy (HCM), myocardial fibrosis is routinely shown by
late gadolinium enhancement (LGE) in cardiac magnetic resonance (CMR) imaging. We …

Background The value of native myocardial T1 mapping and extracellular volume (ECV)
fraction in patients who have hypertrophic cardiomyopathy (HCM) but no late gadolinium …

Background Late gadolinium enhancement (LGE) is a standard method to evaluate
myocardial fibrosis, but restricted due to contrast agent contraindications. Non-contrast …

Background The presence of myocardial fibrosis is associated with worse clinical outcomes
in hypertrophic cardiomyopathy (HCM). Cardiovascular magnetic resonance (CMR) with late …

Background—Noncontrast magnetic resonance T1 mapping reflects a composite of both
intra-and extracellular signal. We hypothesized that noncontrast T1 mapping can …

Hypertrophic cardiomyopathy (HCM) is a cardiovascular genetic disease with a varied
clinical presentation and phenotype. Although mutations are typically found in genes coding …

Background In hypertrophic cardiomyopathy (HCM), autopsy studies revealed both
increased focal and diffuse deposition of collagen fibers. Late gadolinium enhancement …

PURPOSE: To investigate the diagnostic value of T1 mapping imaging of evaluating fibrosis
in patients with hypertrophic cardiomyopathy (HCM). MATERIALS AND METHODS: 21 …